Article
CD13 is a therapeutic target in human liver cancer stem cells
9 Aug 2010
Abstract excerpt
Cancer stem cells (CSCs) are generally dormant or slowly cycling tumor cells that have the ability to reconstitute tumors. They are thought to be involved in tumor resistance to chemo/radiation therapy and tumor relapse and progression. However, neither their existence nor their identity within many cancers has been well defined. Here, we have demonstrated that CD13 is a marker for semiquiescent CSCs in human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
